Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company
Full stratified findings are provided in Supplementary Materials 2
In research contexts, subcutaneous GHK-Cu injection is being explored for its systemic effects particularly its potential to deliver anti-inflammatory, tissue-regenerative, and gene-expression-modulating effects to tissues beyond the skin, including muscles, joints, internal organs, and the central nervous system
The oral form, with its extremely low bioavailability, cannot achieve the same sustained release
Visible improvements in hair density and thic kness are typically observed w ithin 46 months of consistent use
Already denied and want to appeal